Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
14-3-3 proteins are a highly conserved family of regulatory molecules found in all eukaryotic cells. They function primarily as molecular scaffolds, binding to hundreds of phosphoserine/threonine-containing proteins across diverse signaling pathways. Seven distinct human isoforms exist, often forming homo- or heterodimers. They play crucial roles in signal transduction, cell cycle progression, cell death, and trafficking by altering the conformation, function, or localization of their binding partners. Dysregulation or altered expression of 14-3-3 proteins is implicated in diseases such as cancer and neurodegenerative disorders, and elevated cerebrospinal fluid levels are a diagnostic marker for rapid neurodegeneration. While no approved drugs specifically target these proteins, their protein–protein interaction surfaces are being explored for pharmacological intervention, though safety and specificity remain challenges.
Modulate protein–protein interactions by stabilizing or inhibiting binding between 14-3-3 and partners Affect localization and function of signaling proteins
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 14-3-3 protein (general family; e.g., "14-3-3 protein beta" for specific isoform) (14-3-3).